Name
Fireside chat with Sarepta CEO Doug Ingram
Date & Time
Tuesday, April 23, 2024, 11:45 AM - 12:15 PM
Speakers
Douglas S. Ingram
President and CEO
Sarepta Therapeutics
Lei Lei Wu
Moderator
News Reporter
Endpoints News
Description
Sarepta’s gene therapy for Duchenne was the first in vivo gene therapy to win accelerated approval — a big milestone, and a contentious one. Join us as reporter Lei Lei Wu talks with Sarepta CEO Doug Ingram about the therapy’s rollout and the FDA’s evolving language around complex rare disease drugs.
Virtual Session Link
URL
#